Profusa Announces Listing Transfer to The Nasdaq Capital Market
Profusa, Inc., a digital health company specializing in tissue-integrated biosensors, announced it has transferred its stock listing to the Nasdaq Capital Market effective May 15, 2026. This move aligns with previously disclosed plans to meet Nasdaq's bid price and stockholders' equity requirements to maintain compliance and listing status. Profusa…